Relationship of Hepatitis C Virus Infection With Diabetes in the US Population

被引:67
作者
Ruhl, Constance E. [1 ]
Menke, Andy [1 ]
Cowie, Catherine C. [2 ]
Everhart, James E. [2 ]
机构
[1] Social & Sci Syst Inc, Silver Spring, MD 20910 USA
[2] NIDDK, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
关键词
BETA-CELL FUNCTION; INSULIN-RESISTANCE; LIVER-CIRRHOSIS; PREVALENCE; MELLITUS; METAANALYSIS; IMPACT; RISK; ASSOCIATION; GLUCOSE;
D O I
10.1002/hep.27047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
An association of hepatitis C virus (HCV) infection with diabetes has been reported in many studies, but few have been population based and applied standard criteria for diabetes diagnosis. We examined this relationship using recent population-based data from the U.S. National Health and Nutrition Examination Survey. Adult participants (15,128) in the 1999-2010 surveys had data on diabetes status and serum HCV antibody (anti-HCV) or HCV RNA. Using American Diabetes Association criteria, diabetes was defined as a health care provider diagnosis, serum hemoglobin A(1C) (A1C) 6.5%, or fasting plasma glucose (FPG) 126 mg/dL, prediabetes as A1C 5.7%-<6.5% or FPG 100-<126 mg/dL, and normal glucose as A1C <5.7% and FPG <100 mg/dL. Odds ratios (ORs) for diabetes and prediabetes, comparing persons with HCV infection to those without, were adjusted for demographics, BMI, C-reactive protein, smoking, drinking, and blood transfusion before 1992. Among participants without diabetes, we compared mean insulin resistance (IR), estimated using homeostasis model assessment (HOMA-IR), by HCV status. The overall prevalence of anti-HCV+ was 1.7%, of HCV RNA(+) 1.1%, of diabetes 10.5%, and of prediabetes 32.8%. The prevalence of diabetes and prediabetes did not differ by HCV status. In multivariate-adjusted analysis, diabetes remained unassociated with anti-HCV (OR, 1.0; 95% confidence interval [CI]: 0.6-1.7) or with HCV RNA (OR, 1.1; 95% CI: 0.6-1.9). In contrast, elevated alanine aminotransferase and gamma glutamyltransferase activities were associated with diabetes regardless of HCV status. HOMA-IR was not associated with HCV markers in unadjusted or multivariate-adjusted analyses (P > 0.05). Conclusion: In the U.S. population, HCV was not associated with diabetes or with IR among persons with normal glucose. Previously reported relationships of HCV with diabetes were possibly attributable to the effect of elevated liver enzymes. (Hepatology 2014;60:1139-1149)
引用
收藏
页码:1139 / 1149
页数:11
相关论文
共 34 条
[1]   Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus [J].
Arao, M ;
Murase, K ;
Kusakabe, A ;
Yoshioka, K ;
Fukuzawa, Y ;
Ishikawa, T ;
Tagaya, T ;
Yamanouchi, K ;
Ichimiya, H ;
Sameshima, Y ;
Kakumu, S .
JOURNAL OF GASTROENTEROLOGY, 2003, 38 (04) :355-360
[2]   Sustained Virological Response Reduces Incidence of Onset of Type 2 Diabetes in Chronic Hepatitis C [J].
Arase, Yasuji ;
Suzuki, Fumitaka ;
Suzuki, Yoshiyuki ;
Akuta, Norio ;
Kobayashi, Masahiro ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Sezaki, Hitomi ;
Ilosaka, Tetsuya ;
Hirakawa, Miharu ;
Ikeda, Kenji ;
Kumada, Hiromitsu .
HEPATOLOGY, 2009, 49 (03) :739-744
[3]   Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population [J].
Binswanger, I. A. ;
Krueger, P. M. ;
Steiner, J. F. .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2009, 63 (11) :912-919
[4]   Impact of Insulin Resistance on HCV Treatment Response and Impact of HCV Treatment on Insulin Sensitivity Using Direct Measurements of Insulin Action [J].
Brandman, Danielle ;
Bacchetti, Peter ;
Ayala, Claudia E. ;
Maher, Jacquelyn J. ;
Khalili, Mandana .
DIABETES CARE, 2012, 35 (05) :1090-1094
[5]  
Breslow NE, 1987, STATISTICAL METHODS, VII, P48
[6]  
Centers for Disease Control and Prevention, 2010, DIS ROD
[7]   Hepatitis C virus infection in USA: an estimate of true prevalence [J].
Chak, Eric ;
Talal, Andrew H. ;
Sherman, Kenneth E. ;
Schiff, Eugene R. ;
Saab, Sammy .
LIVER INTERNATIONAL, 2011, 31 (08) :1090-1101
[8]   Changes in Insulin Sensitivity and Body Weight During and After Peginterferon and Ribavirin Therapy for Hepatitis C [J].
Conjeevaram, Hari S. ;
Wahed, Abdus S. ;
Afdhal, Nezam ;
Howell, Charles D. ;
Everhart, James E. ;
Hoofnagle, Jay H. .
GASTROENTEROLOGY, 2011, 140 (02) :469-477
[9]   Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the US Population in 1988-2006 [J].
Cowie, Catherine C. ;
Rust, Keith F. ;
Byrd-Holt, Danita D. ;
Gregg, Edward W. ;
Ford, Earl S. ;
Geiss, Linda S. ;
Bainbridge, Kathleen E. ;
Fradkin, Judith E. .
DIABETES CARE, 2010, 33 (03) :562-568
[10]   Review article: type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy [J].
Fabris, P ;
Floreani, A ;
Tositti, G ;
Vergani, D ;
De Lalla, F ;
Betterle, C .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (06) :549-558